Modifying the potassium concentration used for dialysis may decrease mortality risk among hospitalized patients with end-stage kidney disease and severe hyperkalemia, according to investigators.
Patient characteristics, such as dialysis use and diabetes status, appeared to be influential factors.
The placebo response is statistically, and possibly clinically, significant in patients with OAB, according to authors of a new systematic review.
Bone loss in patients with kidney stone disease, particularly in men, has been underappreciated in clinical practice, according to investigators.
Nearly 80% of patients in a recent study had very low serum zinc values, which raises concern for the advanced CKD population at large, according to investigators.
Biopsy results support a SARS-CoV-2 kidney tropism in both proximal and distal tubules, according to the investigators, despite the absence of definitive ultrastructural evidence.
The effects of combined verinurad and febuxostat treatment were independent of blood pressure.
Study findings suggest NSAIDs may be a risk factor for acute kidney injury and hyperkalemia in patients with diabetes.
Additional safety data on testosterone therapy are needed before it can be used to prevent type 2 diabetes.
Higher proportions of patients in the low to middle income brackets were diagnosed with localized renal cell carcinoma in states allowing Medicaid expansion.
